Global Androstenedione Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 121

Report ID: 5259

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
The global Androstenedione market is valued at 190 million US$ in 2018 and will reach 210 million US$ by the end of 2025, growing at a CAGR of 0.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Androstenedione market based on company, product type, end user and key regions.

This report studies the global market size of Androstenedione in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Androstenedione in these regions.
This research report categorizes the global Androstenedione market by top players/brands, region, type and end user. This report also studies the global Androstenedione market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BIOVET
Indo Phyto Chemicals
Sito Bio
Goto Pharmaceutical
Tianjin King York
Jiufu
Yongning Pharma
Jiangxi Hongyuan Pharmaceutical
Kaizon
Xi’an Gaoyuan Bio-Chem
Dongyao Pharmaceutical
Huazhong Pharmaceutical
Darui
Danjiangkou Danao
Dahua Pharmaceutical

Market size by Product
4-AD
ADD
Market size by End User
Arthritis Pharmaceuticals
Fertility Control Pharmaceuticals
Infectious Inflammation Pharmaceuticals
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Androstenedione market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Androstenedione market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Androstenedione companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Androstenedione submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Androstenedione are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Androstenedione market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Androstenedione Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Androstenedione Market Size Growth Rate by Product
1.4.2 4-AD
1.4.3 ADD
1.5 Market by End User
1.5.1 Global Androstenedione Market Size Growth Rate by End User
1.5.2 Arthritis Pharmaceuticals
1.5.3 Fertility Control Pharmaceuticals
1.5.4 Infectious Inflammation Pharmaceuticals
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Androstenedione Market Size
2.1.1 Global Androstenedione Revenue 2014-2025
2.1.2 Global Androstenedione Sales 2014-2025
2.2 Androstenedione Growth Rate by Regions
2.2.1 Global Androstenedione Sales by Regions
2.2.2 Global Androstenedione Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Androstenedione Sales by Manufacturers
3.1.1 Androstenedione Sales by Manufacturers
3.1.2 Androstenedione Sales Market Share by Manufacturers
3.1.3 Global Androstenedione Market Concentration Ratio (CR5 and HHI)
3.2 Androstenedione Revenue by Manufacturers
3.2.1 Androstenedione Revenue by Manufacturers (2014-2019)
3.2.2 Androstenedione Revenue Share by Manufacturers (2014-2019)
3.3 Androstenedione Price by Manufacturers
3.4 Androstenedione Manufacturing Base Distribution, Product Types
3.4.1 Androstenedione Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Androstenedione Product Type
3.4.3 Date of International Manufacturers Enter into Androstenedione Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Androstenedione Sales by Product
4.2 Global Androstenedione Revenue by Product
4.3 Androstenedione Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Androstenedione Breakdown Data by End User

6 North America
6.1 North America Androstenedione by Countries
6.1.1 North America Androstenedione Sales by Countries
6.1.2 North America Androstenedione Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Androstenedione by Product
6.3 North America Androstenedione by End User

7 Europe
7.1 Europe Androstenedione by Countries
7.1.1 Europe Androstenedione Sales by Countries
7.1.2 Europe Androstenedione Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Androstenedione by Product
7.3 Europe Androstenedione by End User

8 Asia Pacific
8.1 Asia Pacific Androstenedione by Countries
8.1.1 Asia Pacific Androstenedione Sales by Countries
8.1.2 Asia Pacific Androstenedione Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Androstenedione by Product
8.3 Asia Pacific Androstenedione by End User

9 Central & South America
9.1 Central & South America Androstenedione by Countries
9.1.1 Central & South America Androstenedione Sales by Countries
9.1.2 Central & South America Androstenedione Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Androstenedione by Product
9.3 Central & South America Androstenedione by End User

10 Middle East and Africa
10.1 Middle East and Africa Androstenedione by Countries
10.1.1 Middle East and Africa Androstenedione Sales by Countries
10.1.2 Middle East and Africa Androstenedione Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Androstenedione by Product
10.3 Middle East and Africa Androstenedione by End User

11 Company Profiles
11.1 BIOVET
11.1.1 BIOVET Company Details
11.1.2 Company Business Overview
11.1.3 BIOVET Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.1.4 BIOVET Androstenedione Products Offered
11.1.5 BIOVET Recent Development
11.2 Indo Phyto Chemicals
11.2.1 Indo Phyto Chemicals Company Details
11.2.2 Company Business Overview
11.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Indo Phyto Chemicals Androstenedione Products Offered
11.2.5 Indo Phyto Chemicals Recent Development
11.3 Sito Bio
11.3.1 Sito Bio Company Details
11.3.2 Company Business Overview
11.3.3 Sito Bio Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sito Bio Androstenedione Products Offered
11.3.5 Sito Bio Recent Development
11.4 Goto Pharmaceutical
11.4.1 Goto Pharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Goto Pharmaceutical Androstenedione Products Offered
11.4.5 Goto Pharmaceutical Recent Development
11.5 Tianjin King York
11.5.1 Tianjin King York Company Details
11.5.2 Company Business Overview
11.5.3 Tianjin King York Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Tianjin King York Androstenedione Products Offered
11.5.5 Tianjin King York Recent Development
11.6 Jiufu
11.6.1 Jiufu Company Details
11.6.2 Company Business Overview
11.6.3 Jiufu Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Jiufu Androstenedione Products Offered
11.6.5 Jiufu Recent Development
11.7 Yongning Pharma
11.7.1 Yongning Pharma Company Details
11.7.2 Company Business Overview
11.7.3 Yongning Pharma Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Yongning Pharma Androstenedione Products Offered
11.7.5 Yongning Pharma Recent Development
11.8 Jiangxi Hongyuan Pharmaceutical
11.8.1 Jiangxi Hongyuan Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Products Offered
11.8.5 Jiangxi Hongyuan Pharmaceutical Recent Development
11.9 Kaizon
11.9.1 Kaizon Company Details
11.9.2 Company Business Overview
11.9.3 Kaizon Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Kaizon Androstenedione Products Offered
11.9.5 Kaizon Recent Development
11.10 Xi’an Gaoyuan Bio-Chem
11.10.1 Xi’an Gaoyuan Bio-Chem Company Details
11.10.2 Company Business Overview
11.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Products Offered
11.10.5 Xi’an Gaoyuan Bio-Chem Recent Development
11.11 Dongyao Pharmaceutical
11.12 Huazhong Pharmaceutical
11.13 Darui
11.14 Danjiangkou Danao
11.15 Dahua Pharmaceutical

12 Future Forecast
12.1 Androstenedione Market Forecast by Regions
12.1.1 Global Androstenedione Sales Forecast by Regions 2019-2025
12.1.2 Global Androstenedione Revenue Forecast by Regions 2019-2025
12.2 Androstenedione Market Forecast by Product
12.2.1 Global Androstenedione Sales Forecast by Product 2019-2025
12.2.2 Global Androstenedione Revenue Forecast by Product 2019-2025
12.3 Androstenedione Market Forecast by End User
12.4 North America Androstenedione Forecast
12.5 Europe Androstenedione Forecast
12.6 Asia Pacific Androstenedione Forecast
12.7 Central & South America Androstenedione Forecast
12.8 Middle East and Africa Androstenedione Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Androstenedione Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer